Liu Wei, Sun Meng, Zhang Hao, Wang Wen-Ting, Song Jian, Wang Meng-Yang, Wang Chun-Mei, Sun Hai-Ming
College of Pharmacy, Beihua University, Jilin 132013, China.
College of Pharmacy, Beihua University, Jilin 132013, China.
Int J Biol Macromol. 2025 May;306(Pt 3):141660. doi: 10.1016/j.ijbiomac.2025.141660. Epub 2025 Mar 1.
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common chronic diseases in the world, and the effective treatment of NAFLD has been listed as a key problem to be solved urgently in contemporary medicine. Polysaccharides in traditional Chinese medicine (TCM) have a wide range of pharmacological activities. A large number of preclinical studies have confirmed that TCM polysaccharides can interfere with the occurrence and development of NAFLD at multiple interrelated levels, such as improving lipid metabolism and insulin resistance, regulating oxidative stress, alleviating immune inflammatory response, and regulating intestinal microbiota, thus showing great potential as a new anti-NAFLD drug. This paper summarizes the prevention and treatment effect and mechanism of TCM polysaccharides on NAFLD, which provides a basis for the application of TCM polysaccharides in plant medicine and modern medicines, and provides a reference for promoting the development and utilization of TCM polysaccharide resources and the research and development of new drugs for NAFLD.
非酒精性脂肪性肝病(NAFLD)已成为世界上最常见的慢性疾病之一,NAFLD的有效治疗已被列为当代医学亟待解决的关键问题。中药多糖具有广泛的药理活性。大量临床前研究证实,中药多糖可在多个相互关联的层面干扰NAFLD的发生发展,如改善脂质代谢和胰岛素抵抗、调节氧化应激、减轻免疫炎症反应以及调节肠道微生物群,因此作为一种新型抗NAFLD药物显示出巨大潜力。本文综述了中药多糖对NAFLD的防治作用及机制,为中药多糖在植物药和现代药物中的应用提供依据,为推动中药多糖资源的开发利用以及NAFLD新药研发提供参考。